These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 27107424)

  • 61. Acidified bile acids enhance tumor progression and telomerase activity of gastric cancer in mice dependent on c-Myc expression.
    Wang X; Sun L; Wang X; Kang H; Ma X; Wang M; Lin S; Liu M; Dai C; Dai Z
    Cancer Med; 2017 Apr; 6(4):788-797. PubMed ID: 28247570
    [TBL] [Abstract][Full Text] [Related]  

  • 62. BRD4 promotes gastric cancer progression through the transcriptional and epigenetic regulation of c-MYC.
    Ba M; Long H; Yan Z; Wang S; Wu Y; Tu Y; Gong Y; Cui S
    J Cell Biochem; 2018 Jan; 119(1):973-982. PubMed ID: 28681984
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Differential expression of CD44 and CD24 markers discriminates the epitheliod from the fibroblastoid subset in a sarcomatoid renal carcinoma cell line: evidence suggesting the existence of cancer stem cells in both subsets as studied with sorted cells.
    Hsieh CH; Hsiung SC; Yeh CT; Yen CF; Chou YW; Lei WY; Pang ST; Chuang CK; Liao SK
    Oncotarget; 2017 Feb; 8(9):15593-15609. PubMed ID: 28121626
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
    Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
    Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
    [TBL] [Abstract][Full Text] [Related]  

  • 65. c-Myc Alteration Determines the Therapeutic Response to FGFR Inhibitors.
    Liu H; Ai J; Shen A; Chen Y; Wang X; Peng X; Chen H; Shen Y; Huang M; Ding J; Geng M
    Clin Cancer Res; 2017 Feb; 23(4):974-984. PubMed ID: 27401245
    [No Abstract]   [Full Text] [Related]  

  • 66. miR‑494 inhibits cancer‑initiating cell phenotypes and reverses resistance to lapatinib by downregulating FGFR2 in HER2‑positive gastric cancer.
    Yu Y; Yu X; Liu H; Song Q; Yang Y
    Int J Mol Med; 2018 Aug; 42(2):998-1007. PubMed ID: 29786108
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A CD44v
    Hu J; Li G; Zhang P; Zhuang X; Hu G
    Cell Death Dis; 2017 Mar; 8(3):e2679. PubMed ID: 28300837
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
    He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
    Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Gene expression profiling of MYC-driven tumor signatures in porcine liver stem cells by transcriptome sequencing.
    Aravalli RN; Talbot NC; Steer CJ
    World J Gastroenterol; 2015 Feb; 21(7):2011-29. PubMed ID: 25717234
    [TBL] [Abstract][Full Text] [Related]  

  • 70. HER2 interacts with CD44 to up-regulate CXCR4 via epigenetic silencing of microRNA-139 in gastric cancer cells.
    Bao W; Fu HJ; Xie QS; Wang L; Zhang R; Guo ZY; Zhao J; Meng YL; Ren XL; Wang T; Li Q; Jin BQ; Yao LB; Wang RA; Fan DM; Chen SY; Jia LT; Yang AG
    Gastroenterology; 2011 Dec; 141(6):2076-2087.e6. PubMed ID: 21925125
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Nanovesicle-mediated systemic delivery of microRNA-34a for CD44 overexpressing gastric cancer stem cell therapy.
    Jang E; Kim E; Son HY; Lim EK; Lee H; Choi Y; Park K; Han S; Suh JS; Huh YM; Haam S
    Biomaterials; 2016 Oct; 105():12-24. PubMed ID: 27497057
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Aberrant hypermethylation of the FGFR2 gene in human gastric cancer cell lines.
    Park S; Kim JH; Jang JH
    Biochem Biophys Res Commun; 2007 Jun; 357(4):1011-5. PubMed ID: 17459342
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of gastric cancer stem cell on gastric cancer invasion, migration and angiogenesis.
    Zhu Z; Xu J; Li L; Ye W; Xu G; Chen B; Zeng J; Li J; Huang Z
    Int J Med Sci; 2020; 17(13):2040-2051. PubMed ID: 32788883
    [No Abstract]   [Full Text] [Related]  

  • 74. [Ponatinib inhibits growth of patient-derived xenograft of cholangiocarcinoma expressing FGFR2-CCDC6 fusion protein in nude mice].
    Wu T; Jiang X; Xu B; Wang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Oct; 40(10):1448-1456. PubMed ID: 33118510
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Chimeric 5/35 adenovirus-mediated Dickkopf-1 overexpression suppressed tumorigenicity of CD44⁺ gastric cancer cells via attenuating Wnt signaling.
    Wang B; Liu J; Ma LN; Xiao HL; Wang YZ; Li Y; Wang Z; Fan L; Lan C; Yang M; Hu L; Wei Y; Bian XW; Chen D; Wang J
    J Gastroenterol; 2013 Jul; 48(7):798-808. PubMed ID: 23188090
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Establishment of a human colorectal cancer cell line P6C with stem cell properties and resistance to chemotherapeutic drugs.
    Rao GH; Liu HM; Li BW; Hao JJ; Yang YL; Wang MR; Wang XH; Wang J; Jin HJ; Du L; Chen Q
    Acta Pharmacol Sin; 2013 Jun; 34(6):793-804. PubMed ID: 23736004
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Synergistic effects of CD44 and TGF-β1 through AKT/GSK-3β/β-catenin signaling during epithelial-mesenchymal transition in liver cancer cells.
    Park NR; Cha JH; Jang JW; Bae SH; Jang B; Kim JH; Hur W; Choi JY; Yoon SK
    Biochem Biophys Res Commun; 2016 Sep; 477(4):568-574. PubMed ID: 27320862
    [TBL] [Abstract][Full Text] [Related]  

  • 78. STAT5A modulates gastric cancer progression via upregulation of CD44.
    Wang S; Fan R; Gao H; Ma X; Wu Y; Xing Y; Wang Y; Jia Y
    Genomics; 2023 May; 115(3):110638. PubMed ID: 37196931
    [TBL] [Abstract][Full Text] [Related]  

  • 79. YWHAE silencing induces cell proliferation, invasion and migration through the up-regulation of CDC25B and MYC in gastric cancer cells: new insights about YWHAE role in the tumor development and metastasis process.
    Leal MF; Ribeiro HF; Rey JA; Pinto GR; Smith MC; Moreira-Nunes CA; Assumpção PP; Lamarão LM; Calcagno DQ; Montenegro RC; Burbano RR
    Oncotarget; 2016 Dec; 7(51):85393-85410. PubMed ID: 27863420
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Metformin treatment decreases the expression of cancer stem cell marker CD44 and stemness related gene expression in primary oral cancer cells.
    Patil S
    Arch Oral Biol; 2020 May; 113():104710. PubMed ID: 32208194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.